Dissertation/Thesis Abstract

In Vivo Efficacy of Lanthanum Carbonate on Intestinal Phosphorus Absorption in Stage Five Chronic Kidney Disease Patients Undergoing Peritoneal Dialysis
by Lyzlov, Alexei, M.S., California State University, Long Beach, 2017, 67; 10690632
Abstract (Summary)

The central focus of the study was to quantify, under precisely controlled metabolic balance condition, the increase in fecal excretion of dietary phosphorus that occurs when CPD patients ingest lanthanum carbonate. The dose response relationship between lanthanum carbonate treatment and fecal phosphorus excretion under constant phosphorus intake condition was determined. Suggesting that doses between 3.0 grams of lanthanum carbonate per day and 4.5 grams are optimal for all the patients participated in the study. Finally the body phosphorus balance was calculated under each of the lanthanum carbonate doses and was determined to be negative for all the patients under 4.5 g/day or lanthanum carbonate.

Indexing (document details)
Advisor: Weers, Paul
Commitee: Kopple, Joel, Slowinska, Katarzyna
School: California State University, Long Beach
Department: Chemistry and Biochemistry
School Location: United States -- California
Source: MAI 57/01M(E), Masters Abstracts International
Subjects: Biochemistry
Publication Number: 10690632
ISBN: 978-0-355-48828-9
Copyright © 2021 ProQuest LLC. All rights reserved. Terms and Conditions Privacy Policy Cookie Policy